Metformin Mitigates Fibrosis and Glucose Intolerance Induced by Doxorubicin in Subcutaneous Adipose Tissue

Doxorubicin (DX) is a chemotherapeutic drug that is used in clinical practice that promotes deleterious side effects in non-tumor tissues such as adipose tissue. We showed that DX leads to extensive damage in adipose tissue via a disruption in 5′-adenosine monophosphate-activated protein kinase (AMP...

Descripción completa

Detalles Bibliográficos
Autores principales: Biondo, Luana A., Batatinha, Helena A., Souza, Camila O., Teixeira, Alexandre A. S., Silveira, Loreana S., Alonso-Vale, Maria I., Oyama, Lila M., Alves, Michele J., Seelaender, Marilia, Neto, José C. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952005/
https://www.ncbi.nlm.nih.gov/pubmed/29867463
http://dx.doi.org/10.3389/fphar.2018.00452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952005/
https://www.ncbi.nlm.nih.gov/pubmed/29867463
http://dx.doi.org/10.3389/fphar.2018.00452

Ejemplares similares